Desired weight loss and its association with health, health behaviors and perceptions in an adult population with weight excess: One-year follow-up.

Mediterranean diet PREDIMED-plus trial desired weight loss health perception metabolic syndrome

Journal

Frontiers in nutrition
ISSN: 2296-861X
Titre abrégé: Front Nutr
Pays: Switzerland
ID NLM: 101642264

Informations de publication

Date de publication:
2022
Historique:
received: 15 01 2022
accepted: 27 06 2022
entrez: 8 8 2022
pubmed: 9 8 2022
medline: 9 8 2022
Statut: epublish

Résumé

Metabolic syndrome (MetS) worsens quality of life and increases mortality. Dissatisfaction with weight in patients with MetS may modify the effect of lifestyle interventions to achieve changes in health-related behaviors. To assess 1-year changes in cardiovascular risk scores, self-perceived general health and health-related behaviors according to observed changes in desired weight loss during the first year of intervention in a large cardiovascular prevention trial. Prospective analysis of the PREDIMED-PLUS trial, including 5,499 adults (55-75 years old) with overweight or obesity at baseline. The desired weight loss was the difference between ideal and measured weight. Tertiles of change in desired weight loss (1 year vs. baseline) were defined by the following cut-off points: ≥0.0 kg (T1, BMI decreased at T2 and T3 (T1: 0.3, T2: -0.7, T3: -1.9). The most significant improvement in diet quality was observed at T3. Cardiovascular risk decreased at T2 and T3. Mean reductions in MetS severity score were: -0.02 at T1, -0.39 at T2 and -0.78 at T3. The perception of physical health increases in successive tertiles. In older adults with MetS, more ambitious desired weight loss goals were associated with improvements in diet, cardiovascular health and perceived physical health during the first year of a healthy lifestyle intervention programme. Weight dissatisfaction needs to be considered by health professionals. http://www.isrctn.com/ISRCTN89898870, identifier 89898870.

Sections du résumé

Background UNASSIGNED
Metabolic syndrome (MetS) worsens quality of life and increases mortality. Dissatisfaction with weight in patients with MetS may modify the effect of lifestyle interventions to achieve changes in health-related behaviors.
Objective UNASSIGNED
To assess 1-year changes in cardiovascular risk scores, self-perceived general health and health-related behaviors according to observed changes in desired weight loss during the first year of intervention in a large cardiovascular prevention trial.
Design UNASSIGNED
Prospective analysis of the PREDIMED-PLUS trial, including 5,499 adults (55-75 years old) with overweight or obesity at baseline.
Methods UNASSIGNED
The desired weight loss was the difference between ideal and measured weight. Tertiles of change in desired weight loss (1 year vs. baseline) were defined by the following cut-off points: ≥0.0 kg (T1,
Results UNASSIGNED
BMI decreased at T2 and T3 (T1: 0.3, T2: -0.7, T3: -1.9). The most significant improvement in diet quality was observed at T3. Cardiovascular risk decreased at T2 and T3. Mean reductions in MetS severity score were: -0.02 at T1, -0.39 at T2 and -0.78 at T3. The perception of physical health increases in successive tertiles.
Conclusions UNASSIGNED
In older adults with MetS, more ambitious desired weight loss goals were associated with improvements in diet, cardiovascular health and perceived physical health during the first year of a healthy lifestyle intervention programme. Weight dissatisfaction needs to be considered by health professionals.
Clinical trial registration UNASSIGNED
http://www.isrctn.com/ISRCTN89898870, identifier 89898870.

Identifiants

pubmed: 35938116
doi: 10.3389/fnut.2022.848055
pmc: PMC9355147
doi:

Types de publication

Journal Article

Langues

eng

Pagination

848055

Informations de copyright

Copyright © 2022 Bouzas, Bibiloni, Garcia, Mateos, Martínez-González, Salas-Salvadó, Corella, Goday, Martínez, Alonso-Gómez, Wärnberg, Vioque, Romaguera, Lopez-Miranda, Estruch, Tinahones, Lapetra, Serra-Majem, Riquelme-Gallego, Martín-Sánchez, Pintó, Gaforio, Matía, Vidal, Vázquez, Daimiel, Ros, Pascual-Roquet-Jalmar, Babio, Gonzalez-Monge, Castañer, Abete, Sorto-Sánchez, Carlos Benavente-Marín, Torres-Collado, Martin, García-Ríos, Castro-Barquero, Fernández-García, Santos-Lozano, Fernandez-Lazaro, Salas-Huetos, Guillem-Saiz, Zomeño, Ángeles Zulet, Goikoetxea-Bahon, Gea, Nishi, Schröder, Tur and the PREDIMED-Plus investigators.

Déclaration de conflit d'intérêts

Author JS-S reports serving on the board of and receiving grant support through his institution from the International Nut and Dried Fruit Council, and Eroski Foundation. Reports serving in the Executive Committee of the Instituto Danone Spain and on the Scientific Committee of the Danone International Institute. He has received research support from the Patrimonio Comunal Olivarero, Spain and Borges S.A., Spain. Reports receiving consulting fees or travel expenses from Danone; Eroski Foundation; Instituto Danone—Spain; and Abbot Laboratories. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer MM-A declared a shared affiliation with the author BR-G to the handling editor at the time of review.

Références

Int J Environ Res Public Health. 2019 May 09;16(9):
pubmed: 31075869
Medicine (Baltimore). 2017 Nov;96(45):e8491
pubmed: 29137039
J Nutr. 2011 Jun;141(6):1140-5
pubmed: 21508208
Nutrients. 2020 Jul 16;12(7):
pubmed: 32708828
Obes Rev. 2014 Mar;15(3):169-82
pubmed: 24118750
Ann Behav Med. 2020 Nov 1;54(11):904-914
pubmed: 32333673
Rev Esp Cardiol (Engl Ed). 2019 Nov;72(11):925-934
pubmed: 30287240
Eat Weight Disord. 2013 Dec;18(4):351-8
pubmed: 24022273
Semergen. 2020 Nov - Dec;46(8):524-537
pubmed: 32540410
Am J Epidemiol. 2009 Aug 15;170(4):456-63
pubmed: 19546153
Br J Nutr. 2010 Jun;103(12):1808-16
pubmed: 20102675
Obes Rev. 2018 Dec;19(12):1659-1666
pubmed: 30261553
Circulation. 1998 May 12;97(18):1837-47
pubmed: 9603539
Clin Nutr. 2019 Jun;38(3):1221-1231
pubmed: 30651193
BMC Public Health. 2019 May 22;19(1):619
pubmed: 31113396
Obes Rev. 2018 Mar;19(3):347-363
pubmed: 29266851
J Clin Psychol. 1983 Jul;39(4):507-11
pubmed: 6874988
Clin Psychol Rev. 2019 Nov;73:101753
pubmed: 31715442
Med Clin (Barc). 1998 Oct 10;111(11):410-6
pubmed: 9834913
Prev Med. 2016 Jul;88:189-95
pubmed: 27095322
Am J Hum Biol. 2020 Jul;32(4):e23384
pubmed: 31944464
Biomedica. 2019 Dec 01;39(4):647-662
pubmed: 31860177
BMC Public Health. 2016 Jan 22;16:60
pubmed: 26801241
BMC Obes. 2016 Sep 21;3:40
pubmed: 27688891
Rev Assoc Med Bras (1992). 2019 Jun 03;65(5):731-738
pubmed: 31166453
Metabolism. 2019 Dec;101:153988
pubmed: 31672441
Diabetes Metab. 2019 Apr;45(2):140-151
pubmed: 29249613
Adolescence. 2002 Summer;37(146):373-93
pubmed: 12144166
Scand J Public Health. 2017 May;45(3):322-330
pubmed: 28181462
Nutrients. 2020 Apr 07;12(4):
pubmed: 32272653
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Addict Behav. 1996 Mar-Apr;21(2):217-22
pubmed: 8730524
Arq Bras Cardiol. 2003 Mar;80(3):235-49
pubmed: 12856268
PLoS One. 2018 Jun 14;13(6):e0198841
pubmed: 29902214
Obes Res. 2005 Nov;13(11):1961-9
pubmed: 16339128
Eat Behav. 2020 Jan;36:101368
pubmed: 32065974
N Engl J Med. 2018 Jun 21;378(25):e34
pubmed: 29897866
Am J Prev Med. 2014 Jan;46(1):17-23
pubmed: 24355667
Curr Opin Psychiatry. 2011 Jan;24(1):41-8
pubmed: 21088582
Am Psychol. 1997 Dec;52(12):1280-300
pubmed: 9414606
Prev Med. 2018 Aug;113:41-50
pubmed: 29753805
Public Health Nutr. 2005 Oct;8(7):920-7
pubmed: 16277809
Clin Obes. 2020 Aug;10(4):e12362
pubmed: 32352240
BMC Public Health. 2016 Apr 29;16:365
pubmed: 27129700
J Affect Disord. 2020 Sep 1;274:929-934
pubmed: 32664034
Public Health Nutr. 2014 Aug;17(8):1689-96
pubmed: 23941862
BMC Public Health. 2017 Jan 6;17(1):39
pubmed: 28061761
Obesity (Silver Spring). 2020 Feb;28(2):421-428
pubmed: 31970912
Int J Epidemiol. 2019 Apr 1;48(2):387-388o
pubmed: 30476123
Endocrinol Nutr. 2012 Apr;59(4):239-45
pubmed: 22424595
Obes Res. 2004 Dec;12(12):2005-12
pubmed: 15687402
J Prim Prev. 2020 Feb;41(1):1-14
pubmed: 31828501
Appetite. 2016 Jul 1;102:3-14
pubmed: 26829371
Sci Rep. 2017 Aug 15;7(1):8159
pubmed: 28811618
Obes Facts. 2017;10(2):139-151
pubmed: 28434008
PLoS One. 2017 Jan 13;12(1):e0168148
pubmed: 28085886

Auteurs

Cristina Bouzas (C)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, Palma de Mallorca, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain.

Maria Del Mar Bibiloni (MDM)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, Palma de Mallorca, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain.

Silvia Garcia (S)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, Palma de Mallorca, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain.

David Mateos (D)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, Palma de Mallorca, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain.

Miguel Ángel Martínez-González (MÁ)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Preventive Medicine and Public Health, Instituto de Investigación Sanitaria de Navarra (IDISNA), University of Navarra, Pamplona, Spain.
Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA, United States.

Jordi Salas-Salvadó (J)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Human Nutrition Unit, Biochemistry and Biotechnology Department, Institut d'Investigació Sanitària Pere Virgili (IISPV), Hospital Universitari Sant Joan de Reus, Universitat Rovira i Virgili, Tarragona, Spain.

Dolores Corella (D)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Preventive Medicine, University of Valencia, Valencia, Spain.

Albert Goday (A)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d'Investigació Mèdica (IMIM), Barcelona, Spain.

J Alfredo Martínez (JA)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Cardiometabolics Precision Nutrition Program, Instituto Madrileño de Estudios Avanzados (IMDEA) Food, Campus Excelencia Internacional (CEI UAM + CSIC), Madrid, Spain.
Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, Pamplona, Spain.

Ángel M Alonso-Gómez (ÁM)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.
Osakidetza Basque Health Service, Araba University Hospital, Vitoria-Gasteiz, Spain.
Department of Medicine, University of the Basque Country, Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), Vitoria-Gasteiz, Spain.

Julia Wärnberg (J)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Nursing, School of Health Sciences, University of Málaga-IBIMA, Málaga, Spain.

Jesús Vioque (J)

Instituto de Investigación Sanitaria y Biomédica de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL-UMH), Alicante, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

Dora Romaguera (D)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain.

José Lopez-Miranda (J)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba, Spain.

Ramon Estruch (R)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Internal Medicine, Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Hospital Clinic, University of Barcelona, Barcelona, Spain.

Francisco J Tinahones (FJ)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Virgen de la Victoria Hospital, Department of Endocrinology, University of Málaga, Málaga, Spain.

José Lapetra (J)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Research Unit, Department of Family Medicine, Distrito Sanitario Atención Primaria Sevilla, Sevilla, Spain.

Lluís Serra-Majem (L)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Institute for Biomedical Research, University of Las Palmas de Gran Canaria, Las Palmas, Spain.

Blanca Riquelme-Gallego (B)

CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Preventive Medicine, University of Granada, Granada, Spain.

Vicente Martín-Sánchez (V)

CIBER Diabetes y enfermedades metabólicas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Institute of Biomedicine (IBIOMED), University of León, Leon, Spain.

Xavier Pintó (X)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Lipids and Vascular Risk Unit, Internal Medicine, Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.

José J Gaforio (JJ)

Department of Nursing, School of Health Sciences, University of Málaga-IBIMA, Málaga, Spain.
Department of Health Sciences, Center for Advanced Studies in Olive Grove and Olive Oils, University of Jaen, Jaen, Spain.

Pilar Matía (P)

Department of Endocrinology and Nutrition, Fundación Para la Investigación Biomedica de El Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Josep Vidal (J)

Department of Endocrinology, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Hospital Clinic, University of Barcelona, Barcelona, Spain.

Clotilde Vázquez (C)

Department of Endocrinology, Fundación Jiménez-Díaz, Madrid, Spain.

Lidia Daimiel (L)

Nutritional Control of the Epigenome Group, Precision Nutrition and Obesity Program, IMDEA Food, Campus Excelencia Internacional (CEI UAM + CSIC), Madrid, Spain.

Emilio Ros (E)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Lipid Clinic, Department of Endocrinology and Nutrition, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain.

Elena Pascual-Roquet-Jalmar (E)

Department of Preventive Medicine and Public Health, Instituto de Investigación Sanitaria de Navarra (IDISNA), University of Navarra, Pamplona, Spain.
Osasunbidea, Servicio Navarro de Salud, Atención Primaria, Pamplona, Spain.

Nancy Babio (N)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Human Nutrition Unit, Biochemistry and Biotechnology Department, Institut d'Investigació Sanitària Pere Virgili (IISPV), Hospital Universitari Sant Joan de Reus, Universitat Rovira i Virgili, Tarragona, Spain.

Inmaculada Gonzalez-Monge (I)

Department of Preventive Medicine, University of Valencia, Valencia, Spain.

Olga Castañer (O)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d'Investigació Mèdica (IMIM), Barcelona, Spain.

Itziar Abete (I)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Preventive Medicine and Public Health, Instituto de Investigación Sanitaria de Navarra (IDISNA), University of Navarra, Pamplona, Spain.

Carolina Sorto-Sánchez (C)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.
Osakidetza Basque Health Service, Araba University Hospital, Vitoria-Gasteiz, Spain.
Department of Medicine, University of the Basque Country, Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), Vitoria-Gasteiz, Spain.

Juan Carlos Benavente-Marín (J)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Nursing, School of Health Sciences, University of Málaga-IBIMA, Málaga, Spain.

Laura Torres-Collado (L)

Instituto de Investigación Sanitaria y Biomédica de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL-UMH), Alicante, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

Marian Martin (M)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain.

Antonio García-Ríos (A)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba, Spain.

Sara Castro-Barquero (S)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Internal Medicine, Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Hospital Clinic, University of Barcelona, Barcelona, Spain.

Jose C Fernández-García (JC)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Virgen de la Victoria Hospital, Department of Endocrinology, University of Málaga, Málaga, Spain.

José Manuel Santos-Lozano (JM)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Research Unit, Department of Family Medicine, Distrito Sanitario Atención Primaria Sevilla, Sevilla, Spain.

Cesar I Fernandez-Lazaro (CI)

Department of Preventive Medicine and Public Health, Instituto de Investigación Sanitaria de Navarra (IDISNA), University of Navarra, Pamplona, Spain.

Albert Salas-Huetos (A)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Human Nutrition Unit, Biochemistry and Biotechnology Department, Institut d'Investigació Sanitària Pere Virgili (IISPV), Hospital Universitari Sant Joan de Reus, Universitat Rovira i Virgili, Tarragona, Spain.

Patricia Guillem-Saiz (P)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Preventive Medicine, University of Valencia, Valencia, Spain.

María Dolores Zomeño (MD)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d'Investigació Mèdica (IMIM), Barcelona, Spain.

Maria Ángeles Zulet (M)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Preventive Medicine and Public Health, Instituto de Investigación Sanitaria de Navarra (IDISNA), University of Navarra, Pamplona, Spain.

Amaia Goikoetxea-Bahon (A)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.
Osakidetza Basque Health Service, Araba University Hospital, Vitoria-Gasteiz, Spain.
Department of Medicine, University of the Basque Country, Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), Vitoria-Gasteiz, Spain.

Alfredo Gea (A)

Department of Preventive Medicine and Public Health, Instituto de Investigación Sanitaria de Navarra (IDISNA), University of Navarra, Pamplona, Spain.

Stephanie K Nishi (SK)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Human Nutrition Unit, Biochemistry and Biotechnology Department, Institut d'Investigació Sanitària Pere Virgili (IISPV), Hospital Universitari Sant Joan de Reus, Universitat Rovira i Virgili, Tarragona, Spain.

Helmut Schröder (H)

Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d'Investigació Mèdica (IMIM), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

Josep A Tur (JA)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, Palma de Mallorca, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain.

Classifications MeSH